Health Care Complimentary Full-text Medicinal Assistance For The Treatment Of Obesity Existing And Future
Cetilistat (a lipase inhibitor in Phase I trials), dapagliflozin (a SGLT2 inhibitor in Phase III), empagliflozin (a SGLT2 inhibitor in Stage III) [55], and dirlotapide (an MTP prevention permitted for pet dogs) belong to this group (Table 2). Information in panel a refer to liraglutide 3 mg (ref.176), orlistat289, naltrexone/bupropion292, phentermine/topiramate291, semaglutide 1 mg (ref.125),…